peptide crafters bpc 157 BPC-157 - Research-Grade | COA Verified BPC-157 – Research Peptide |
Description
Mild injection-site soreness or temporary B-vitamin flush may occur
This is based on its ability to counteract ketamine and MK-801, NMDA receptor antagonists that model negative-like schizophrenia symptoms in rodents
This could be due to a variety of reasons such as genetic factors, underlying health conditions like pernicious anaemia, or gastrointestinal surgery
However, a localized injection is often preferred in research to achieve a higher concentration at the target site
Mandala Publications
The EFSA bases their recommendations on intake , as distinct from the amount absorbed used by the IOM
